“IRBM is an important Italian biotech centre , which is giving a strategic contribution to the development of one of the vaccines against Covid-19 , a very important reality from the scientific point of view at international level.
“Only a safe, effective vaccine can take us out of the emergency. “We are proud of our scientists and of the excellence of Italian research” said minister Speranza.
“We are grateful to the Minister of Health, Roberto Speranza, for the visit, together with the General Manager of Aifa, Nicola Magrini, to our company and gratified by his words of appreciation for the work done by the researchers of Irbm. We also thank him, moreover, for bringing Italy in the group of government leaders for the contract for the production and distribution of the vaccine that we are testing,” said Di Lorenzo.